Loading company…
ID 434167171 · FY 2019–2024 · 6 years
საზოგადოების ძირითად საქმიანობას წარმოადგენს სამედიცინო მოწყობილობა დანადგარებით ვაჭრობა ფინანსური ანგარიშგება მომზადდა ბუღალტრული აღრიცხვის საერტაშორისო სტანდარტების დებულებების შესაბამისად.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross Margin | 15.1% | 14.6% | 13.2% | 24.8% | 22.1% | 11.7% |
| EBITDA Margin | 13.4% | 10.9% | -1.5% | 8.8% | 15.2% | 7.8% |
| EBITDAR | 564 | 503 | -94 | 263 | 862 | 607 |
| EBITDAR Margin | 13.4% | 10.9% | -1.5% | 8.8% | 15.2% | 7.8% |
| EBIT Margin | 13.4% | 10.9% | -1.5% | 8.8% | 15.2% | 7.8% |
| Net Profit Margin | 13.4% | 10.9% | -4.5% | 8.8% | 14.4% | 6.0% |
| Operating Expense % of Sales | 1.7% | 3.7% | 14.7% | 16.0% | 6.9% | 3.9% |
| Returns | ||||||
| Return on Assets (ROA) | 48.6% | 28.4% | -18.3% | 21.5% | 44.4% | 18.0% |
| Return on Equity (ROE) | 95.4% | 51.9% | -41.4% | 31.9% | 63.8% | 40.2% |
| ROIC [EBIT / Invested Capital] | 61.7% | 33.3% | -16.5% | 40.3% | 100.5% | N/A |
| Leverage & liquidity | ||||||
| Debt-to-Assets | 49.0% | 44.9% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.96x | 0.82x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 1.01x | 1.58x | N/A | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 50.9% | 54.7% | 44.3% | 67.4% | 69.6% | 44.8% |
| Net Debt | 323 | 543 | -113 | -172 | -421 | -1,201 |
| Cash & Equivalents | 246 | 251 | 113 | 172 | 421 | 1,201 |
| Total Debt | 569 | 794 | N/A | N/A | N/A | N/A |
| Efficiency & working capital | ||||||
| Inventory Turnover | 12.36x | 3.97x | 58.07x | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | 29.5 | 91.9 | 6.3 | N/A | N/A | N/A |
| Receivables Turnover | 6.74x | 8.88x | 4.76x | 6.04x | 9.93x | 10.01x |
| Days Sales Outstanding (DSO) | 54.2 | 41.1 | 76.6 | 60.4 | 36.8 | 36.5 |
| Payables Turnover | N/A | N/A | 6.35x | 5.62x | 7.92x | 4.84x |
| Days Payable Outstanding (DPO) | N/A | N/A | 57.5 | 64.9 | 46.1 | 75.4 |
| Cash Conversion Cycle | 83.7 days | 133.1 days | 25.4 days | -4.5 days | -9.3 days | -38.9 days |
| Asset Turnover | 3.63x | 2.61x | 4.07x | 2.44x | 3.09x | 3.01x |
| Cash flow & dividends | ||||||
| Operating Cash Flow | N/A | 5 | -138 | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | 5 | -138 | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | 1.0% | N/A | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.